*Please ensure you have downloaded the most recent version of Zoom to take part in this interactive session, you will appear on screen to take part in focused group discussions*

ROUNDTABLE
1. Controlling off-target degradation and monitoring toxicity - Daohong Zhou, Professor of Pharmacodynamics, University of Florida
2. Dealing with resistance in response to protein degraders against oncogenic proteins of interest. - Shanique Alabi, Crews Lab, Yale
3. What defines potency and constitutes a good degradation event? - Xiaozhang Zheng, Senior Director of Chemistry, Kymera Therapeutics
4. Optimizing specificity of E3 ligases to protein of interest - Ksenya Cohen Katsenelson Senior Scientist Group Leader, R&D